Skip to main content
Top
Published in:

Open Access 14-02-2024 | Leishmania | Research

Portable smartphone-based molecular test for rapid detection of Leishmania spp.

Authors: Rea Maja Kobialka, Arianna Ceruti, Madhurima Roy, Sutopa Roy, Rajashree Chowdhury, Prakash Ghosh, Faria Hossain, Manfred Weidmann, Elena Graf, Jesus Bueno Alvarez, Javier Moreno, Uwe Truyen, Dinesh Mondal, Mitali Chatterjee, Ahmed Abd El Wahed

Published in: Infection | Issue 4/2024

Login to get access

Abstract

Purpose

Leishmaniasis, caused by the parasite of the genus Leishmania, is a neglected tropical disease which is endemic in more than 60 countries. In South-East Asia, Brazil, and East Africa, it mainly occurs as kala-azar (visceral leishmaniasis, VL), and subsequently as post kala-azar dermal leishmaniasis (PKDL) in a smaller portion of cases. As stated per WHO roadmap, accessibility to accurate diagnostic methods is an essential step to achieve elimination. This study aimed to test the accuracy of a portable minoo device, a small battery-driven, multi-use fluorimeter operating with isothermal technology for molecular diagnosis of VL and PKDL.

Methods

Fluorescence data measured by the device within 20 min are reported back to the mobile application (or app) via Bluetooth and onward via the internet to a backend. This allows anonymous analysis and storage of the test data. The test result is immediately returned to the app displaying it to the user.

Results

The limit of detection was 11.2 genome copies (95% CI) as determined by screening a tenfold dilution range of whole Leishmania donovani genomes using isothermal recombinase polymerase amplification (RPA). Pathogens considered for differential diagnosis were tested and no cross-reactivity was observed. For its diagnostic performance, DNA extracted from 170 VL and PKDL cases, comprising peripheral blood samples (VL, n = 96) and skin biopsies (PKDL, n = 74) from India (n = 108) and Bangladesh (n = 62), was screened. Clinical sensitivity and specificity were 88% and 91%, respectively.

Conclusion

Minoo devices can offer a convenient, cheaper alternative to other molecular diagnostics. Its easy handling makes it ideal for use in low-resource settings to identify parasite burden.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Portable smartphone-based molecular test for rapid detection of Leishmania spp.
Authors
Rea Maja Kobialka
Arianna Ceruti
Madhurima Roy
Sutopa Roy
Rajashree Chowdhury
Prakash Ghosh
Faria Hossain
Manfred Weidmann
Elena Graf
Jesus Bueno Alvarez
Javier Moreno
Uwe Truyen
Dinesh Mondal
Mitali Chatterjee
Ahmed Abd El Wahed
Publication date
14-02-2024
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2024
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-024-02179-z

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more